Total Payments
$2,339
2023 Payments
$136.77
Companies
13
Transactions
112
Medicare Patients
2,188
Medicare Billing
$165,211
Payment Breakdown by Category
Food & Beverage$2,100 (89.8%)
Education$238.98 (10.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,100 | 109 | 89.8% |
| Education | $238.98 | 3 | 10.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $895.51 | 44 | $0 (2022) |
| Janssen Biotech, Inc. | $384.85 | 22 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $376.04 | 5 | $0 (2022) |
| PFIZER INC. | $195.75 | 13 | $0 (2021) |
| Lilly USA, LLC | $151.23 | 8 | $0 (2021) |
| Aurinia Pharma U.S., Inc. | $122.94 | 7 | $0 (2023) |
| UCB, Inc. | $66.29 | 4 | $0 (2021) |
| ARBOR PHARMACEUTICALS, INC. | $41.80 | 3 | $0 (2021) |
| Actelion Pharmaceuticals US, Inc. | $28.97 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.87 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $136.77 | 4 | Janssen Biotech, Inc. ($79.99) |
| 2022 | $259.04 | 4 | Mallinckrodt Hospital Products Inc. ($99.00) |
| 2021 | $1,943 | 104 | Amgen Inc. ($810.53) |
All Payment Transactions
112 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/26/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 08/05/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 07/13/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 03/14/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $79.99 | General |
| Category: Immunology | ||||||
| 06/23/2022 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $84.98 | General |
| Category: Inflammation | ||||||
| 06/02/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $59.99 | General |
| Category: Immunology | ||||||
| 05/17/2022 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $99.00 | General |
| Category: IMMUNOLOGY | ||||||
| 01/19/2022 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $15.07 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/29/2021 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: Immunology | ||||||
| 12/27/2021 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: Immunology | ||||||
| 12/22/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/21/2021 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: Immunology | ||||||
| 12/16/2021 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $13.01 | General |
| Category: Immunology | ||||||
| 12/15/2021 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: Inflammation | ||||||
| 12/09/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Bone Health | ||||||
| 12/08/2021 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: Inflammation | ||||||
| 12/08/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 12/06/2021 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: Immunology | ||||||
| 11/30/2021 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 11/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $24.87 | General |
| 11/16/2021 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Immunology | ||||||
| 11/11/2021 | Amgen Inc. | AVSOLA (Biological), Enbrel | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Inflammation | ||||||
| 11/10/2021 | NOVARTIS PHARMACEUTICALS CORPORATION | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2021 | Alexion Pharmaceuticals, Inc. | Strensiq (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Endocrinology | ||||||
| 11/08/2021 | Janssen Biotech, Inc. | TREMFYA (Drug), SIMPONI ARIA | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 358 | 513 | $126,940 | $36,022 |
| 2022 | 8 | 678 | 1,754 | $159,213 | $44,378 |
| 2021 | 12 | 1,136 | 3,345 | $259,879 | $84,579 |
| 2020 | 1 | 16 | 24 | $1,782 | $231.33 |
Total Patients
2,188
Total Services
5,636
Medicare Billing
$165,211
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 276 | 418 | $102,410 | $29,835 | 29.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 28 | $9,800 | $2,677 | 27.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 33 | $5,280 | $1,768 | 33.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 28 | 34 | $9,450 | $1,743 | 18.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 315 | 412 | $103,630 | $27,974 | 27.0% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 11 | 660 | $26,400 | $11,259 | 42.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 42 | 44 | $7,030 | $1,804 | 25.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 27 | 36 | $8,715 | $1,417 | 16.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 202 | 255 | $2,550 | $750.37 | 29.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 22 | 22 | $4,438 | $619.66 | 14.0% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 25 | 35 | $2,100 | $298.95 | 14.2% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 34 | 290 | $4,350 | $254.96 | 5.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 511 | 633 | $154,885 | $48,981 | 31.6% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 26 | 1,560 | $62,100 | $26,066 | 42.0% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 47 | 58 | $8,700 | $2,659 | 30.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 34 | 34 | $5,950 | $1,863 | 31.3% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 45 | 45 | $9,570 | $1,352 | 14.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 325 | 422 | $3,376 | $1,262 | 37.4% |
| 73120 | X-ray of hand, 2 views | Office | 2021 | 24 | 48 | $3,360 | $886.47 | 26.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 53 | 467 | $6,995 | $464.62 | 6.6% |
| 20605 | Aspiration and/or injection of medium joint or joint capsule | Office | 2021 | 15 | 15 | $1,700 | $451.87 | 26.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 34 | 38 | $2,090 | $343.90 | 16.5% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2021 | 11 | 11 | $803.00 | $194.58 | 24.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 11 | 14 | $350.00 | $54.30 | 15.5% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 16 | 24 | $1,782 | $231.33 | 13.0% |
About Ann Rogers, ARNP
Ann Rogers, ARNP is a Emergency healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/22/2017. The National Provider Identifier (NPI) number assigned to this provider is 1891204871.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ann Rogers, ARNP has received a total of $2,339 in payments from pharmaceutical and medical device companies, with $136.77 received in 2023. These payments were reported across 112 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,100).
As a Medicare-enrolled provider, Rogers has provided services to 2,188 Medicare beneficiaries, totaling 5,636 services with total Medicare billing of $165,211. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency
- Other Specialties Rheumatology, Family
- Location Omaha, NE
- Active Since 09/22/2017
- Last Updated 06/17/2024
- Taxonomy Code 163WE0003X
- Entity Type Individual
- NPI Number 1891204871
Products in Payments
- ACTHAR (Biological) $376.04
- Enbrel (Biological) $372.70
- TREMFYA (Drug) $371.51
- EVENITY (Biological) $212.14
- AVSOLA (Biological) $156.46
- Otezla (Drug) $154.21
- XELJANZ (Drug) $152.40
- TALTZ (Drug) $151.23
- LUPKYNIS (Drug) $122.94
- Cimzia (Drug) $66.29
- Horizant (Drug) $41.80
- INFLECTRA (Biological) $27.90
- KEVZARA (Biological) $19.24
- Strensiq (Drug) $19.16
- OPSUMIT (Drug) $16.66
- SIMPONI ARIA (Biological) $13.34
- UPTRAVI (Drug) $12.31
- COSENTYX (Biological) $12.00
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.